1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2016-2021 Future Horizons and Growth Strategies in the Global Pap Smear/HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 257 pages and 21 tables

Table Of Contents

2016-2021 Future Horizons and Growth Strategies in the Global Pap Smear/HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
I. Introduction
II. PAP Smear/HPV Worldwide Market and Technology Overview
A. PAP Smear/HPV: Clinical Significance
and Laboratory Practices
B. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra 400
12. Inverness DS2
13. JandJ Vitros ECi/ECiQ
14. JandJ Vitros 3600
15. JandJ Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra 400
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista 500
28. Siemens Immulite

29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy 500
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others

4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
D. Personal Testing
III. France: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares
IV. Germany: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares

VI. Japan: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares
VII. Spain: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares
VIII. U.K.: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares
IX. U.S.A.: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares

X. Design Criteria for Decentralized Testing Products
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. Competitive Profiles

- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics/Theradiag
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid

- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix/Clinical Genomics
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Tosoh
- Veridex
- Vermillion
- Wako Pure Chemicals
- Wallac/PE
- Zila


List of Tables
Major Companies Developing or Marketing Pap Smear/HPV Tests
France
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
France
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Germany
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
Germany
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Italy
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
Italy
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Japan
PAP Smear Test Volume and Diagnostics Sales
by Market Segment

Japan
Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Spain
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
U.K.
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
U.K.
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
U.S.A. Pap Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

Global Cervical Cancer Diagnostic Testing Market 2016-2020

Global Cervical Cancer Diagnostic Testing Market 2016-2020

  • $ 2500
  • Industry report
  • December 2016
  • by Infiniti Research Limited

About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. ...

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast

Global Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear, HPV DNA, VIA) Forecast

  • $ 1990
  • Industry report
  • February 2017
  • by Renub Research

Global Cervical Market is expected to be close to US$ 7 Billion by 2020. North America controls almost 50 percent Cervical Cancer Market. United States and Japan together makes more than 50 percent market ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.